Compounds displaying consistent similarity across multiple fingerprint classes were selected for downstream filtering
IRR, incidence rate ratio
Treatment Effective management of MASLD in individuals with T2DM requires addressing not only hepatic steatosis, inflammation, and fibrosis but also the broader cardiometabolic risk profile that drives disease progression and long-term hepatic and extrahepatic complications (Chouik et al., 2025[15]
Very professional and courteous
3.3.5 Other efficacy of GLP-1 RAs in MASLD Anthropometric measurements, including body weight, BMI, WC, SAT, and VAT, as well as inflammatory factors, such as CRP, were also included in the meta-analyses (Supplementary Table S6)
The diet should be nutritionally balanced, with less than 30% of calories from fat